Showing 441-460 of 642 for: Cochrane Systematic Reviews > Cardiovascular 
- Pegloticase for chronic gout
Cochrane Systematic Reviews, 17-Feb-2010
Pegloticase is a potential new treatment option for patients with chronic gout intolerant to other urate-lowering therapies.
- Pelvic floor muscle training versus no treatment, or inactive control treatments, for urinary incontinence in women
Cochrane Systematic Reviews, 13-May-2014
Pelvic floor muscle training is the most commonly used physical therapy treatment for women with stress urinary incontinence (SUI). It is sometimes also recommended for mixed and, less commonly, urgency urinary incontinence.
- Penicillin for secondary prevention of rheumatic fever
Cochrane Systematic Reviews, 15-Jan-2013
People with a history of rheumatic fever are at high risk of recurrent attacks of rheumatic fever and developing rheumatic heart disease following a streptococcal throat infection. Giving penicillin to these people can prevent recurrent attacks of rheumat
- Pentoxifylline for intermittent claudication
Cochrane Systematic Reviews, 16-Sep-2015
Intermittent claudication (IC) is a symptom of peripheral arterial disease (PAD) and is associated with high morbidity and mortality. Pentoxifylline, one of many drugs used to treat IC, acts by decreasing blood viscosity, improving erythrocyte flexibility
- Pentoxifylline for treating venous leg ulcers
Cochrane Systematic Reviews, 30-Oct-2012
Healing of venous leg ulcers is improved by the use of compression bandaging but some venous ulcers remain unhealed, and some people are unsuitable for compression therapy. Pentoxifylline, a drug which helps blood flow, has been used to treat venous leg u
- Pentoxifylline, propentofylline and pentifylline for acute ischaemic stroke
Cochrane Systematic Reviews, 16-Sep-2008
Methylxanthine derivatives are vasodilators. They also inhibit platelet aggregation and thromboxane A2 synthesis, decrease the release of free radicals and may be neuroprotective. This review covers an area where no active research is taking place. It wil
- Percutaneous transluminal angioplasty and stenting for vertebral artery stenosis
Cochrane Systematic Reviews, 21-Sep-2008
Surgery for vertebral artery stenosis is technically difficult, potentially hazardous and is not considered in most centres. There is growing evidence from case series that vertebral artery stenosis may be treated endovascularly by percutaneous translumin
- Percutaneous transluminal coronary angioplasty with stents versus coronary artery bypass grafting for people with stable angina or acute coronary syndromes
Cochrane Systematic Reviews, 17-Dec-2012
Coronary artery bypass graft surgery (CABG) replaces obstructed vessels with ones from other parts of the body. Alternatively, obstructions are remodelled using catheter-based techniques such as percutaneous coronary angioplasty with the use of stents. Th
- Percutaneous transluminal rotational atherectomy for coronary artery disease
Cochrane Systematic Reviews, 13-Nov-2012
This is an update of the review on 'Percutaneous transluminal rotational atherectomy for coronary artery disease' first published in The Cochrane Library Issue 4, 2003. Percutaneous transluminal coronary rotational atherectomy (PTCRA) debulks atherosclero
- Percutaneous vascular interventions for acute ischaemic stroke
Cochrane Systematic Reviews, 23-Aug-2010
Most disabling strokes are due to blockage of a large artery in the brain by a blood clot. Prompt removal of the clot with intra-arterial thrombolytic drugs or mechanical devices, or both, can restore blood flow before major brain damage has occurred, lea
- Perioperative administration of buffered versus non‐buffered crystalloid intravenous fluid to improve outcomes following adult surgical procedures
Cochrane Systematic Reviews, 21-Sep-2017
Perioperative fluid strategies influence clinical outcomes following major surgery. Many intravenous fluid preparations are based on simple solutions, such as normal saline, that feature an electrolyte composition that differs from that of physiological p
- Perioperative increase in global blood flow to explicit defined goals and outcomes following surgery
Cochrane Systematic Reviews, 1-Jul-2013
Studies have suggested that increasing whole body blood flow and oxygen delivery around the time of surgery reduces mortality, morbidity and the expense of major operations.
- Pharmaceutical interventions for emotionalism after stroke
Cochrane Systematic Reviews, 17-Nov-2022
Antidepressants may be useful in the treatment of abnormal crying associated with stroke. This is an update of a Cochrane Review first published in 2004 and last updated in 2019.
- Pharmacological cardioversion for atrial fibrillation and flutter
Cochrane Systematic Reviews, 8-Sep-2008
Atrial fibrillation is the commonest cardiac dysrhythmia. It is associated with significant morbidity and mortality. There are two approaches to the management of atrial fibrillation: controlling the ventricular rate or converting to sinus rhythm in the e
- Pharmacological interventions for hypertensive emergencies
Cochrane Systematic Reviews, 12-Nov-2008
Hypertensive emergencies, marked hypertension associated with acute end-organ damage, are life-threatening conditions. Many anti-hypertensive drugs have been used in these clinical settings. The benefits and harms of such treatment and the best first-line
- Pharmacological management for agitation and aggression in people with acquired brain injury
Cochrane Systematic Reviews, 13-May-2008
Of the many psychiatric symptoms that may result from brain injury, agitation and/or aggression are often the most troublesome. It is therefore important to evaluate the efficacy of psychotropic medication used in its management.
- Pharmacological treatment for aphasia following stroke
Cochrane Systematic Reviews, 23-Mar-2010
Aphasia describes language impairment associated with a brain lesion.
- Pharmacotherapy for hypertension in the elderly
Cochrane Systematic Reviews, 9-Nov-2010
Elevated blood pressure (known as hypertension) increases with age, and most rapidly over age 60. Systolic hypertension is more strongly associated with cardiovascular disease than diastolic hypertension, and occurs more commonly in older people. It is
- Pharmacotherapy for hypertension in women of different races
Cochrane Systematic Reviews, 12-Aug-2008
Although hypertension treatment in women is recommended to decrease the risk of cardiovascular disease (Wenger 1993, Kaplan 1995, Kuhn 1993, Hayes 1998, JNCVI,1997), the evidence for treatment benefit is primarily based on combined results for men and wom
- Pharmacotherapy for mild hypertension
Cochrane Systematic Reviews, 31-May-2014
People with no previous cardiovascular events or cardiovascular disease represent a primary prevention population. The benefits and harms of treating mild hypertension in primary prevention patients are not known at present. This review examines the exist
